Skip to main content
. 2019 Jul 23;106(6):1338–1345. doi: 10.1002/cpt.1553

Table 1.

Baseline characteristics

Characteristic Patients, = 287
Age, years 50.2 ± 9.3
Height, cm 167.8 ± 7.0
Center
Radboud University Medical Center – n (%) 222 (77)
University Hospital Leuven – n (%) 65 (23)
Diagnosis
ADPKD, n (%) 181 (63)
ADPLD, n (%) 106 (37)
TLV, mL 3,514a (2,400–4,971)
hTLV, mL/m 2,095a (1,419–3,015)
Severity classification:b
Mild (<1,600 mL/m), n (%) 87 (30)
Moderate (1,600–3,200 mL/m), n (%) 139 (48)
Severe (>3,200 mL/m) – no. (%) 61 (21)
Ln hTLV, mL/m 7.66 ± 0.53
Age at menarche, year 13.2 ± 1.5
Pregnancies, yes (%) 236 (82)
No. of pregnancies 2.6 ± 1.3
No. of months pregnant 20.5 ± 8.6
Breastfeeding, yes (%) 165 (70)
No. of months breastfeeding 10.1 ± 9.1
Fertility treatment, yes (%) 15 (5.2)
Estrogen‐containing contraception, yes (%) 268 (93)
Estrogen‐containing contraception, year 14.1 ± 8.6
Progestin‐only oral contraceptives, yes (%) 13 (5)
IUD, yes (%) 65 (23)
Menopausal status
Premenopausal, n (%) 114 (40)
Postmenopausal, n (%) 115 (40)
Age at menopause 50.1 ± 4.5
Uncertain/unknown, n (%) 22 (8)
Hysterectomy/oophorectomy before scan, n (%) 36 (13)

ADPKD, autosomal dominant polycystic kidney disease; ADPLD, autosomal dominant polycystic liver disease; hTLV, height‐adjusted total liver volume; IUD, intrauterine device; Ln, natural logarithm; TLV, total liver volume. Plus–minus values are means ± SD.

aNonparametric values expressed as median (interquartile range (IQR)). bSeverity classification is based on hTLV (mL/m).